| Nuvayda Integrative Health | |
|
23456 Hawthorne Blvd Suite 260 Torrance CA 90505-4716 | |
| (310) 504-0783 | |
| (424) 257-8432 |
| Full Name | Nuvayda Integrative Health |
|---|---|
| Speciality | Clinic/center |
| Location | 23456 Hawthorne Blvd, Torrance, California |
| Authorized Official Name and Position | Farid Khan (MANAGING PARTNER) |
| Authorized Official Contact | 3105040783 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Nuvayda Integrative Health 23456 Hawthorne Blvd Suite 260 Torrance CA 90505-4716 Ph: (310) 504-0783 | Nuvayda Integrative Health 23456 Hawthorne Blvd Suite 260 Torrance CA 90505-4716 Ph: (310) 504-0783 |
| NPI Number | 1013389253 |
|---|---|
| Provider Enumeration Date | 10/27/2015 |
| Last Update Date | 10/27/2015 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013389253 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
When multidisciplinary health care teams were engaged in caring for patients suffering from refractory cardiogenic shock, a severe condition that can occur after a heart attack, the likelihood of survival increased significantly, by approximately 50 percent.
Synta Pharmaceuticals Corp. - Ganetespib, a potent, second generation Hsp90 inhibitor, has demonstrated clinical activity in heavily pre-treated patients with HER2-positive and triple negative metastatic breast cancer according to Phase 2 clinical trial results presented by researchers from Memorial Sloan-Kettering Cancer Center at the San Antonio Breast Cancer Symposium.
The discovery of an inhibitor of the Insulin Degrading Enzyme (IDE), a protein responsible for the susceptibility of diabetes because it destroys insulin in the body, may lead to new treatment approaches for diabetes.
Doctors regularly monitor the level of an immune cell in the blood called a CD4 cell in HIV-infected individuals, to decide when to start treatment and when to change medications.
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). An analysis of long-term efficacy data demonstrated that blinatumomab produced prolonged remissions in patients with ALL. As of November 2010, the hematologic disease free survival (DFS) was 60%, with a follow-up of up to 27.5 months.
› Verified 3 days ago
Southbay Endocrine Medical Associates Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 20911 Earl St, Suite 340, Torrance, CA 90503 Phone: 310-802-7002 Fax: 310-542-4695 | |
Delamo Family Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3475 Torrance Blvd Ste G, Torrance, CA 90503 Phone: 310-543-1695 Fax: 310-792-2321 | |
Dunja Maglica Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23441 Madison St Ste 305, Torrance, CA 90505 Phone: 310-378-5115 Fax: 310-378-9779 | |
Torrance Memorial Physician Network Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2900 Lomita Blvd, Torrance, CA 90505 Phone: 310-784-3740 Fax: 310-539-1006 | |
David H. Stern, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1218 Crenshaw Blvd, Torrance, CA 90501 Phone: 310-328-1181 Fax: 310-328-1747 | |
Medical Associates Of Little Company Of Mary Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 21311 Madrona Ave, 100a, Torrance, CA 90503 Phone: 310-792-4400 Fax: 310-542-5805 | |
Bliss Medical Group, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23451 Madison St, Suite 250, Torrance, CA 90505 Phone: 310-791-0083 Fax: 310-791-0085 |